Walvax Biotechnology Co.,Ltd.’s Net Profit Rose 197.1% in First Quarter of 2023

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (300142.SZ) reported a net profit of 198.3 million yuan in the first quarter of 2023, up 197.1% year-on-year.

Meanwhile, the company posted 833.3 million yuan in revenue, up 27% year-on-year.

At the end of the reporting period, it had 15.4 billion yuan in total assets and 4.2 billion yuan in total liabilities, with a liability-to-asset ratio of 27.5%.